HB1613
Type: B Origin: House USA Comments: 0

Drug Price Transparency In Medicaid Act Of 2023

AI Summary
User Reviews

The Drug Price Transparency in Medicaid Act of 2023 aims to increase transparency in drug pricing within the Medicaid program. The bill includes provisions that require drug manufacturers to provide detailed information on pricing and costs associated with their products to the Department of Health and Human Services. It also mandates the publication of this pricing data to ensure accountability and enable better decision-making regarding drug purchasing within Medicaid. This legislation seeks to address rising drug costs, enhance pricing transparency, and promote cost-effective utilization of medications within the Medicaid program.

Bill Activity

  • 2023-03-17: Introduced in House

  • 2023-03-17: Referred to the House Committee on Energy and Commerce.

  • 2023-03-24: Referred to the Subcommittee on Health.

Bill Discussion Board

Share your views on the Bill

User Icon

Min. 50 characters required  |  (0/1000 Character)

Contributions (0)
Add Contribution+2 pts.

Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.